Our Focus
Late stage compounds which enrich regional value
Japan: Oncology, Specialty Medicine
US: Oncology
EU: Synergistic effect on Lixiana
Japan
Late stage or marketed oncology and specialty medicine products
- In CVM (w/ LIXIANA®, EFIENT®, Minnebro, TENELIA®, and Canaglu)
- CNS (w/ Memary® and Vimpat®)
- Orthopedic (w/ PRALIA® and TARLIGE®)
- GI (w/ Nexium®)
- Oncology (w/ VANFLYTA and ENHERTU®)
US
Late stage or marketed oncology products
- Late stage or marketed products in Oncology (w/ENHERTU®)
EU
Late stage or marketed products with a synergistic effect on LIXIANA®
- In CVM (w/ LIXIANA® and Nilemdo/Nustendi) or Oncology (w/ ENHERTU®)
Submit a non-confidential proposal